Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 953-553-3 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / micronucleus study
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 19 October 2021 to 12 November 2021
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 022
- Report date:
- 2022
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 487 (In vitro Mammalian Cell Micronucleus Test)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian cell micronucleus test
Test material
- Reference substance name:
- Fatty acids, palm-oil (C16-C18), Me esters, chlorinated (35-45 % w/w)
- EC Number:
- 953-553-3
- Cas Number:
- 95009-45-3
- Molecular formula:
- It cannot be provided.
- IUPAC Name:
- Fatty acids, palm-oil (C16-C18), Me esters, chlorinated (35-45 % w/w)
- Test material form:
- liquid
- Details on test material:
- Batch number: SV210602R4001
Constituent 1
Method
Species / strain
- Species / strain / cell type:
- lymphocytes:
- Cytokinesis block (if used):
- Cytochalasin B
- Metabolic activation:
- with and without
- Metabolic activation system:
- Sodium phenobarbitone and β-naphthoflavone induced rat liver S9 homogenate was used as the metabolic activation system.
- Test concentrations with justification for top dose:
- The test item was tested at the concentrations of 0.03125, 0.0625 and 0.125 µL/mL for short term in presence and absence of metabolic activation and long-term treatment in the absence of metabolic activation system.
- Vehicle / solvent:
- DMSO
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- colchicine
- cyclophosphamide
- mitomycin C
- Details on test system and experimental conditions:
- The experiment was conducted with and without metabolic activation. The test item was assessed in proliferated lymphocytes in duplicates by exposing for a short term (3 to 6 hours, with and without metabolic activation) and a long term (20 to 24 hours, without metabolic activation)
- Evaluation criteria:
- A test item is considered to be clearly positive if:
At least one of the test concentrations exhibits a statistically significant increase compared with the concurrent negative control.
The increase is dose-related in at least one experimental condition when evaluated with an appropriate trend test.
A test item is considered to be clearly negative if:
None of the test concentrations exhibits a statistically significant increase compared with the concurrent negative control.
There is no concentration-related increase when evaluated with an appropriate trend test. - Statistics:
- ANOVA
Results and discussion
Test results
- Key result
- Species / strain:
- lymphocytes: Human peripheral blood lymphocytes
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- There was no statistically significant increase in the percentage of micronuclei in binucleated cells were observed in any of the tested concentrations when compared to the vehicle control.
Applicant's summary and conclusion
- Conclusions:
- Based on the results obtained, it is concluded that the test item is non clastogenic and/or non aneugenic in cultured human lymphocytes at and up to 0.125 µL/mL both in short term and long-term treatments (presence and absence of metabolic activation) as it showed no evidence of increase in the induction of micronuclei under the test conditions.
- Executive summary:
The test item, ESTERI METILICI ACIDI GRASSI DA OLIO - ESSEBIOCHLOR45 was evaluated for formation of micronuclei in the cytoplasm of interphase cells using human lymphocytes. Test item found miscible in DMSO at 200 µL/mL. Precipitation test was conducted at 0.03125, 0.0625, 0.125, 0.25, 0.5, 1 and 2 µL/mL, post incubation mild precipitation was observed at 2 µL/mL, and no precipitation was observed in any of the concentration tested from 0.03125 to 1 µL/mL. No pH change was observed in any of the concentration tested, hence 2 µL/mL was selected as highest concentration for initial cytotoxicity test and other concentration tested were 0.125, 0.25, 0.5 and 1 µL/mL. The experiment was conducted with and without metabolic activation. The test item was assessed in proliferated lymphocytes in duplicates by exposing for a short term (3 to 6 hours, with and without metabolic activation) and a long term (20 to 24 hours, without metabolic activation). Cytokinesis was blocked using Cytochalasin B, the cells were harvested and slides were prepared. In order to assess the cytotoxicity of the test item, the Cytokinesis-Block Proliferation Index (CBPI) was calculated for cultures treated with the test item and vehicle control. The % cytotoxicity was in the range of 80.33 to 100% at 0.25 to 2 µL/mL. The % cytotoxicity ranged from of 54.10 to 55.00% at 0.125 µL/mL. As the % cytotoxicity was not more than 55±5% at 0.125 µL/mL, same was selected as the highest concentration for the micronucleus test. Other concentrations tested were 0.03125 and 0.0625 µL/mL. In micronucleus test, the test item was tested at the concentrations of 0.03125, 0.0625 and 0.125 µL/mL for short term in presence and absence of metabolic activation and long-term treatment in the absence of metabolic activation system. The test item induced cytotoxicity at 0.125 µL/mL (51.67 to 54.10%) when compared to vehicle control. There was no statistically significant increase in the percentage of micronuclei in binucleated cells were observed in any of the tested concentrations when compared to the vehicle control. Further, the micronucleus frequencies observed for test item treatments fell within acceptable ranges with regard to in-house historical control data. The positive controls resulted increase of the micronuclei frequencies with statistical significance at 95% level of confidence (p<0.05) under identical conditions, when compared with the vehicle control. This demonstrated the sensitivity of test system towards positive control and confirmed that the test conditions were adequate and within the range of historical control.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.